UBS ASSET MANAGEMENT AMERICAS INC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2021$377,535,000
-21.8%
173,979
+26.2%
0.00%
Q2 2021$482,535,000
-91.6%
137,867
-76.3%
0.00%
-100.0%
Q1 2021$5,731,342,000
-8.8%
581,272
+0.3%
0.00%0.0%
Q4 2020$6,285,130,000
-27.4%
579,809
-31.0%
0.00%
-40.0%
Q3 2020$8,657,191,000
-46.1%
840,504
+9.2%
0.01%
-50.0%
Q2 2020$16,067,327,000
+118.0%
769,508
+2.0%
0.01%
+100.0%
Q1 2020$7,371,592,000
+142.5%
754,513
+185.9%
0.01%
+150.0%
Q4 2019$3,040,105,000263,8980.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders